Skip to main content

Graduate Medical Education (GME): NCI Immunotherapy Fellowship

Fellowship Program Director(s): James Gulley, M.D., Ph.D.

This training program is designed for physicians who have completed a medical oncology fellowship program in the United States and who seek specialized training in immunotherapy with clinical trials and clinical trial development. The breadth and depth of opportunities for training in clinical immunotherapy at the Center for Cancer Research (CCR), NCI, are unsurpassed with active clinical programs in therapeutic cancer vaccines, immune checkpoint modulation, adoptive cellular therapies (both TCR transgenic and CAR-T therapy) and antibody-based immunotherapies.
Program Structure

Program Structure
This 1-year program, at the CCR in Bethesda, Maryland, allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy. This fellowship provides opportunities to understand how to design, write and run clinical trials, how to treat patients, how manage toxicities, as well as opportunities to work with multiple experimental agents.

Additional Information

Application Information
To apply, please send your CV, statement of purpose, three personal references, and your documentation of board eligibility status or certification status to

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 05/21/2021

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at